XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 43,635 $ 287,000,021 $ 2,329,195 $ (253,997,878) $ 35,374,973
Balance (in shares) at Dec. 31, 2022 43,635,715        
Stock-based compensation - employees, consultants and directors   2,486,679     2,486,679
Issuance of common stock offerings, net of fees $ 591 2,106,528     2,107,119
Issuance of common stock offerings, net of fees (in shares) 590,348        
ATM fee   (56,702)     (56,702)
Proceeds from exercise of stock options for cash $ 83 213,224     213,307
Proceeds from exercise of stock options for cash (in shares) 82,355        
Issuance of restricted stock units $ 130 403,811     403,941
Issuance of restricted stock units (in shares) 130,091        
Other comprehensive income (loss): foreign translation adjustment     654,792   654,792
Net loss       (22,672,487) (22,672,487)
Balance at Sep. 30, 2023 $ 44,439 292,153,561 2,983,987 (276,670,365) 18,511,622
Balance (in shares) at Sep. 30, 2023 44,438,509        
Balance at Dec. 31, 2022 $ 43,635 287,000,021 2,329,195 (253,997,878) 35,374,973
Balance (in shares) at Dec. 31, 2022 43,635,715        
Balance at Dec. 31, 2023 $ 54,240 305,196,874 529,321 (282,505,272) 23,275,163
Balance (in shares) at Dec. 31, 2023 54,240,265        
Balance at Jun. 30, 2023 $ 44,193 290,199,035 1,328,313 (267,476,845) 24,094,696
Balance (in shares) at Jun. 30, 2023 44,193,696        
Stock-based compensation - employees, consultants and directors   1,086,163     1,086,163
Issuance of common stock offerings, net of fees $ 162 632,232     632,394
Issuance of common stock offerings, net of fees (in shares) 162,078        
Proceeds from exercise of stock options for cash $ 9 15,920     15,929
Proceeds from exercise of stock options for cash (in shares) 7,962        
Issuance of restricted stock units $ 75 220,211     220,286
Issuance of restricted stock units (in shares) 74,773        
Other comprehensive income (loss): foreign translation adjustment     1,655,674   1,655,674
Net loss       (9,193,520) (9,193,520)
Balance at Sep. 30, 2023 $ 44,439 292,153,561 2,983,987 (276,670,365) 18,511,622
Balance (in shares) at Sep. 30, 2023 44,438,509        
Balance at Dec. 31, 2023 $ 54,240 305,196,874 529,321 (282,505,272) 23,275,163
Balance (in shares) at Dec. 31, 2023 54,240,265        
Stock-based compensation - employees, consultants and directors   2,344,671     2,344,671
Warrants issued in connection with long-term debt   690,709     690,709
Issuance of common stock offerings, net of fees $ 53 11,741     11,794
Issuance of common stock offerings, net of fees (in shares) 53,290        
Issuance of restricted stock units $ 205 197,892     198,097
Issuance of restricted stock units (in shares) 207,058        
Other comprehensive income (loss): foreign translation adjustment     (686,246)   (686,246)
Net loss       (12,835,098) (12,835,098)
Balance at Sep. 30, 2024 $ 54,498 308,441,887 (156,925) (295,340,370) 12,999,090
Balance (in shares) at Sep. 30, 2024 54,500,613        
Balance at Jun. 30, 2024 $ 54,306 307,514,758 2,173,818 (293,006,279) 16,736,603
Balance (in shares) at Jun. 30, 2024 54,306,415        
Stock-based compensation - employees, consultants and directors   781,881     781,881
ATM fee   (41,444)     (41,444)
Issuance of restricted stock units $ 192 186,692     186,884
Issuance of restricted stock units (in shares) 194,198        
Other comprehensive income (loss): foreign translation adjustment     (2,330,743)   (2,330,743)
Net loss       (2,334,091) (2,334,091)
Balance at Sep. 30, 2024 $ 54,498 $ 308,441,887 $ (156,925) $ (295,340,370) $ 12,999,090
Balance (in shares) at Sep. 30, 2024 54,500,613